SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-093667
Filing Date
2023-08-21
Accepted
2023-08-21 07:00:20
Documents
12
Period of Report
2023-08-21
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2324224d1_8k.htm   iXBRL 8-K 24475
  Complete submission text file 0001104659-23-093667.txt   199380

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mrns-20230821.xsd EX-101.SCH 3030
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrns-20230821_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrns-20230821_pre.xml EX-101.PRE 22369
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2324224d1_8k_htm.xml XML 3437
Mailing Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS, INC. (Filer) CIK: 0001267813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36576 | Film No.: 231187307
SIC: 2834 Pharmaceutical Preparations